{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:42:57Z","timestamp":1781898177233,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["81000568"],"award-info":[{"award-number":["81000568"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["81001430"],"award-info":[{"award-number":["81001430"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chinese National Basic Research Program (973 program","award":["2007CB507400"],"award-info":[{"award-number":["2007CB507400"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.neuroscience.2011.11.036","type":"journal-article","created":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T15:39:30Z","timestamp":1322753970000},"page":"396-404","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["FLZ protects dopaminergic neuron through activating protein kinase B\/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models"],"prefix":"10.1016","volume":"202","author":[{"given":"X.-Q.","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.-C.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2011.11.036_bib1","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1073\/pnas.0914876107","article-title":"DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway","volume":"107","author":"Aleyasin","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tips.2007.02.006","article-title":"The Akt-GSK-3 signaling cascade in the actions of dopamine","volume":"28","author":"Beaulieu","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.devcel.2007.03.020","article-title":"The two TORCs and Akt","volume":"12","author":"Bhaskar","year":"2007","journal-title":"Dev Cell"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.mam.2006.08.009","article-title":"Neuronal macroautophagy: from development to degeneration","volume":"27","author":"Boland","year":"2006","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pharmthera.2007.02.002","article-title":"Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: two approaches with therapeutic potential in the treatment of neurodegenerative disease","volume":"114","author":"Burke","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","article-title":"Description of Parkinson's disease as a clinical syndrome","volume":"991","author":"Fahn","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1385\/MN:31:1-3:295","article-title":"Pharmacological study of the novel compound FLZ against experimental Parkinson's models and its active mechanism","volume":"31","author":"Feng","year":"2005","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(02)00833-4","article-title":"Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action","volume":"110","author":"Hara","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.brainres.2011.01.093","article-title":"FLZ, a novel HSP27 and HSP70 inducer, protects SH-SY5Y cells from apoptosis caused by MPP(+)","volume":"1383","author":"Kong","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10495-008-0309-3","article-title":"Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps","volume":"14","author":"Levy","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib13","doi-asserted-by":"crossref","first-page":"17648","DOI":"10.1074\/jbc.M110.100867","article-title":"Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo","volume":"285","author":"Lou","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib14","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1523\/JNEUROSCI.3928-08.2008","article-title":"RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation\/activation","volume":"28","author":"Malagelada","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib15","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1523\/JNEUROSCI.3944-09.2010","article-title":"Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease","volume":"30","author":"Malagelada","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib16","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.3292-06.2006","article-title":"RTP801 is elevated in Parkinson brain substantia nigral neurons and mediates death in cellular models of Parkinson's disease by a mechanism involving mammalian target of rapamycin inactivation","volume":"26","author":"Malagelada","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib17","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1212\/01.wnl.0000312515.52545.51","article-title":"Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain","volume":"70","author":"Marras","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib18","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion","volume":"73","author":"Matsuura","year":"1997","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1385\/MN:26:2-3:389","article-title":"Post-genomic era and gene discovery for psychiatric diseases: there is a new art of the trade?","volume":"26","author":"Meloni","year":"2002","journal-title":"Mol Neurobiol"},{"issue":"Suppl 11","key":"10.1016\/j.neuroscience.2011.11.036_bib21","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/mds.20457","article-title":"Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy","volume":"20","author":"Olanow","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib22","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","article-title":"A role for alpha-synuclein in the regulation of dopamine biosynthesis","volume":"22","author":"Perez","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib23","doi-asserted-by":"crossref","first-page":"18757","DOI":"10.1073\/pnas.0606401103","article-title":"Oncoprotein Akt\/PKB induces trophic effects in murine models of Parkinson's disease","volume":"103","author":"Ries","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib24","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib25","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1471-4159.2010.07112.x","article-title":"A neuroprotective role for angiogenin in models of Parkinson's disease","volume":"116","author":"Steidinger","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbapap.2007.08.015","article-title":"Role of mTOR in physiology and pathology of the nervous system","volume":"1784","author":"Swiech","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2010.04.085","article-title":"Meloxicam protects cell damage from 1-methyl-4-phenyl pyridinium toxicity via the phosphatidylinositol 3-kinase\/Akt pathway in human dopaminergic neuroblastoma SH-SY5Y cells","volume":"1344","author":"Tasaki","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib28","doi-asserted-by":"crossref","first-page":"e1217","DOI":"10.1371\/journal.pone.0001217","article-title":"PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis","volume":"2","author":"Thedieck","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature02369","article-title":"Survival signaling by Akt and eIF4E in oncogenesis and cancer therapy","volume":"428","author":"Wendel","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neulet.2008.03.026","article-title":"Association between AKT1 gene and Parkinson's disease: a protective haplotype","volume":"436","author":"Xiromerisiou","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1742-2094-5-21","article-title":"Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity","volume":"5","author":"Zhang","year":"2008","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuropharm.2006.08.020","article-title":"The novel squamosamide derivative (compound FLZ) attenuated 1-methyl, 4-phenyl-pyridinium ion (MPP+)-induced apoptosis and alternations of related signal transduction in SH-SY5Y cells","volume":"52","author":"Zhang","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2011.11.036_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2006.11.015","article-title":"The novel squamosamide derivative FLZ protects against 6-hydroxydopamine-induced apoptosis through inhibition of related signal transduction in SH-SY5Y cells","volume":"561","author":"Zhang","year":"2007","journal-title":"Eur J Pharmacol"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645221101308X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645221101308X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T01:15:48Z","timestamp":1588814148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030645221101308X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":33,"alternative-id":["S030645221101308X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2011.11.036","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}